Literature DB >> 26997375

Serum magnesium level and vascular stiffness in children with chronic kidney disease on regular hemodialysis.

Manal Mohamed Zaher, Manal Abdel-Salam1, Ragaa Abdel-Salam, Randa Sabour, Amal Abd El-Aleem Morsy, Dina Gamal.   

Abstract

Chronic kidney disease (CKD) patients have a high prevalence of vascular calcifications, and cardiovascular disease is the leading cause of death in this population. Magnesium (Mg) depletion may be the missing link between multiple cardiovascular risk factors and the development of atherosclerosis. In this study, we aimed to assess the relationship between serum Mg levels and vascular stiffness in children with CKD on regular hemodialysis (HD). The study included 25 children with CKD on regular HD in our center; the study included also 25 healthy children age-and sex-matched as a control group. Serum Mg levels were measured, and Doppler ultrasound assessment of the intima-media thickness (IMT) and the peak systolic velocities (PSVs) of the main arteries including the (aorta, carotid, and femoral) arteries were recorded in the study patients. There were significantly lower serum Mg levels in children on regular HD than in the controls (1.7 ± 0.43 mg/dL vs. 2.31 ± 0.12 mg/dL, respectively, P = 0.001). There was a significant increase in the aorta and carotid IMT in the study group than in the controls (0.45 ± 0.07 mm vs. 0.40 ± 0.09 mm; 0.98 ± 0.57 mm vs. 0.55 ± 0.1 mm, P = 0.034 and 0.001, respectively), whereas there were no significant differences regarding the PSV of the carotid, aorta, and femoral arteries between the study patients and the controls (P >0.05). A negative correlation was found between serum Mg level with aortic IMT (AIMT) (r = -0.682; P = 0.000). In addition, a significant negative correlation was found between the AIMT with systolic and diastolic blood pressure (r = 0.447, P = 0.025, 0.472, P = 0.017), respectively. We conclude that lower serum Mg levels were associated with vascular calcification in chronic HD children. Confirmation of our results warrants further study.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26997375     DOI: 10.4103/1319-2442.178205

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  5 in total

1.  Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis.

Authors:  Jiachuan Xiong; Ting He; Min Wang; Ling Nie; Ying Zhang; Yiqin Wang; Yunjian Huang; Bing Feng; Jingbo Zhang; Jinghong Zhao
Journal:  J Nephrol       Date:  2019-03-19       Impact factor: 3.902

Review 2.  Magnesium Replacement to Protect Cardiovascular and Kidney Damage? Lack of Prospective Clinical Trials.

Authors:  Juan R Muñoz-Castañeda; María V Pendón-Ruiz de Mier; Mariano Rodríguez; María E Rodríguez-Ortiz
Journal:  Int J Mol Sci       Date:  2018-02-27       Impact factor: 5.923

3.  Associations between the serum magnesium and all-cause or cardiovascular mortality in chronic kidney disease and end-stage renal disease patients: A meta-analysis.

Authors:  Hongyan Liu; Rui Wang
Journal:  Medicine (Baltimore)       Date:  2021-11-12       Impact factor: 1.817

4.  Magnesium Status and Ca/Mg Ratios in a Series of Children and Adolescents with Chronic Diseases.

Authors:  Marlene Fabiola Escobedo-Monge; Enrique Barrado; Joaquín Parodi-Román; María Antonieta Escobedo-Monge; María Carmen Torres-Hinojal; José Manuel Marugán-Miguelsanz
Journal:  Nutrients       Date:  2022-07-18       Impact factor: 6.706

5.  Hypomagnesemia and Short-Term Mortality in Elderly Maintenance Hemodialysis Patients.

Authors:  Caibao Lu; Yiqin Wang; Daihong Wang; Ling Nie; Ying Zhang; Qiuyu Lei; Jiachuan Xiong; Jinghong Zhao
Journal:  Kidney Dis (Basel)       Date:  2019-12-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.